In an effort to expand its presence and introduce its innovations in aesthetic medicine in the Asian market, IT Pharma has held a series of activities in Hong Kong from July 29 to 31. This program included the presentation of Inbiotec Amber, the injectable succinic and hyaluronic acid, by Dr. Lidici Santana, as well as workshops on Mesosinia, visits to clinics and meetings with doctors and strategic KOLs, demonstrating its commitment to excellence and international collaboration.
The agenda began with a meeting with Skyview, strategic partner in China and Dr. Guo, who participated in the workshop/training at the Tsim Sha Tsui clinic, where treatments with Inbiotec Amber for different age groups were discussed. During the day, five to six patients participated, divided into two categories: young people aged 18 to 25, focusing on acne and scar treatments, and adults aged 35 or older, focusing on skin rejuvenation and collagen regeneration. Under the guidance of Dr. Guo and with the collaboration of ten doctors, detailed practices were carried out and results were documented with before and after photos.
The workshop included a presentation by Dr. Lidici Santana on the use of the dermal biostimulator with succinic acid and the application technique she has developed: Mesosinia. The live demonstration and the practical workshop provided a complete educational experience for all attendees. The following day was dedicated to academic visits to various clinics in Hong Kong, facilitating the exchange of knowledge and experiences between local and international professionals. These visits allowed IT Pharma to showcase its applications and discuss possible future collaborations.
This trip not only highlighted IT Pharmar’s advanced applications in aesthetic medicine, but also strengthened relationships with Skyview and aesthetic professionals in the Hong Kong area, a key point for the brand’s development in the Asian continent.
© 2020 ItPharma
